Salmonella enterica serovar Typhi and Paratyphi
Fluoroquinolone non-susceptibility and multi-drug resistance
GRAM estimates the global prevalence of Salmonella enterica serovar Typhi and Paratyphi infections with observed fluoroquinolone non-susceptibility and multi-drug resistance over time. Based on a detailed systematic review and statistical analysis, findings are due for release in 2023.